| 臺大學術典藏 |
2018-09-10T18:07:31Z |
SIRveNIB: Selective internal radiation therapy versus sorafenib in Asia-Pacific patients with hepatocellular carcinoma
|
Chow, P.K.H. and Gandhi, M. and Tan, S.-B. and Khin, M.W. and Khasbazar, A. and Ong, J. and Choo, S.P. and Cheow, P.C. and Chotipanich, C. and Lim, K. and Lesmana, L.A. and Manuaba, T.W. and Yoong, B.K. and Raj, A. and Law, C.S. and Cua, I.H.Y. and Lobo, R.R. and Teh, C.S.C. and Kim, Y.H. and Jong, Y.W. and Han, H.-S. and Bae, S.-H. and Yoon, H.-K. and Lee, R.-C. and Hung, C.-F. and Peng, C.-Y. and Liang, P.-C. and Bartlett, A. and Kok, K.Y.Y. and Thng, C.-H. and Low, A.S.-C. and Goh, A.S.W. and Tay, K.H. and Lo, R.H.G. and Goh, B.K.P. and Ng, D.C.E. and Lekurwale, G. and Liew, W.M. and Gebski, V. and Mak, K.S.W. and Soo, K.C.; PO-CHIN LIANG |
